Articles posted in: Koios News
Koios AI shows perfect performance in invasive lobular carcinoma
A new retrospective review shows our AI-powered cancer recognition software can make diagnosing invasive lobular carcinomas a little easier. By Amerigo Allegretto, AuntMinnie.com staff writer…
Mitsui & Co. invests in U.S. based healthcare technology company Koios Medical
NEW YORK CITY, NY, UNITED STATES, February 28, 2023– Mitsui & Co., Ltd. (“Mitsui”, Head Office: Tokyo, President and CEO: Kenichi Hori) has participated…
AI used to catch cancer in patients with cancelled appointments
AI software for early detection used to catch breast cancer in patients with cancelled appointments due to COVID-19 Chicago, IL, June 2020 — An…
New Findings Show AI Software Improves Breast Cancer Detection and Physician Accuracy
CHICAGO, Dec. 19, 2019 /PRNewswire/ — A New York City based large volume private practice radiology group conducted a quality assurance review that included an 18 month software…
True Detectives: These Human Owls Are Using AI To Catch Cancer
Not much gets past Chad McClennan and his elite detective squad of owls (yes, you read that right). The “chief executive owl” of the…
Koios DS Breast 2.0: Best available AI diagnostic technology
Via CIOAdvisor Apac: The U.S. Food and Drug Administration (FDA) recently issued 510(k) clearance for Koios DS Breast 2.0, an innovative version of the…
FDA Clears Koios DS™ Breast 2.0 to Assist Physicians with AI-Based Software
Koios Medical, Inc has received 510(k) clearance from the U.S. Food and Drug Administration for Koios DS (Decision Support) Breast 2.0, a new version…
Development of Artificial Intelligence in Women’s Health Emphasizes Value
Greg Freiherr of Imaging Technology News stopped by the Koios Medical booth at the 2019 SBI/ACR Breast Imaging Symposium in Hollywood, FL to learn…